NYSE:NEUE NeueHealth (NEUE) Stock Price, News & Analysis → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free NEUE Stock Alerts $6.38 +0.09 (+1.43%) (As of 04/30/2024 ET) Add Compare Share Share Today's Range$6.35▼$6.3850-Day Range$5.82▼$10.1052-Week Range$4.94▼$37.20Volume1,548 shsAverage Volume30,680 shsMarket Capitalization$52.46 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get NeueHealth alerts: Email Address NeueHealth MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside25.3% Upside$8.00 Price TargetShort InterestHealthy0.51% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.09Based on 22 Articles This WeekInsider TradingSelling Shares$230,365 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.83 out of 5 starsMedical Sector614th out of 918 stocksHospital & Medical Service Plans Industry8th out of 10 stocks 3.0 Analyst's Opinion Consensus RatingNeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageNeueHealth has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.51% of the outstanding shares of NeueHealth have been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldNeueHealth does not currently pay a dividend.Dividend GrowthNeueHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NEUE. Previous Next 1.1 News and Social Media Coverage News SentimentNeueHealth has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.34 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 22 news articles for NeueHealth this week, compared to 4 articles on an average week.MarketBeat FollowsOnly 2 people have added NeueHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $230,365.00 in company stock.Percentage Held by Insiders64.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of NeueHealth is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeueHealth is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About NeueHealth Stock (NYSE:NEUE)NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.Read More NEUE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NEUE Stock News HeadlinesMay 1, 2024 | americanbankingnews.comHead to Head Review: NeueHealth (NEUE) versus Its RivalsMay 1, 2024 | americanbankingnews.comNeueHealth (NEUE) versus Its Rivals Financial AnalysisMay 1, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”May 1, 2024 | americanbankingnews.comHead-To-Head Survey: NeueHealth (NEUE) and Its PeersApril 30, 2024 | americanbankingnews.comComparing NeueHealth (NEUE) & Its RivalsApril 30, 2024 | americanbankingnews.comReviewing NeueHealth (NEUE) & Its RivalsApril 30, 2024 | americanbankingnews.comReviewing NeueHealth (NEUE) and Its PeersApril 30, 2024 | americanbankingnews.comContrasting NeueHealth (NEUE) & Its RivalsMay 1, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”April 29, 2024 | americanbankingnews.comAnalyzing NeueHealth (NEUE) and The CompetitionApril 29, 2024 | americanbankingnews.comHead to Head Contrast: NeueHealth (NEUE) versus The CompetitionApril 29, 2024 | americanbankingnews.comUnitedHealth Group (NYSE:UNH) & NeueHealth (NYSE:NEUE) Head-To-Head SurveyApril 29, 2024 | americanbankingnews.comNeueHealth (NEUE) and Its Rivals Head-To-Head AnalysisApril 28, 2024 | americanbankingnews.comNeueHealth (NEUE) vs. The Competition Head to Head AnalysisApril 27, 2024 | americanbankingnews.comNeueHealth (NEUE) & Its Rivals Head-To-Head ComparisonApril 27, 2024 | americanbankingnews.comNeueHealth (NEUE) and The Competition Critical AnalysisApril 26, 2024 | americanbankingnews.comThe Cigna Group (NYSE:CI) vs. NeueHealth (NYSE:NEUE) Head-To-Head ContrastApril 26, 2024 | americanbankingnews.comFinancial Survey: NeueHealth (NYSE:NEUE) & The Cigna Group (NYSE:CI)April 25, 2024 | americanbankingnews.comNeueHealth (NEUE) & Its Rivals Critical AnalysisApril 25, 2024 | americanbankingnews.comCritical Comparison: NeueHealth (NEUE) vs. The CompetitionApril 25, 2024 | americanbankingnews.comNeueHealth (NEUE) & Its Peers Critical AnalysisApril 25, 2024 | americanbankingnews.comReviewing NeueHealth (NEUE) and Its RivalsApril 25, 2024 | americanbankingnews.comNeueHealth (NEUE) and The Competition Financial ContrastApril 25, 2024 | americanbankingnews.comNeueHealth (NEUE) vs. The Competition Financial ReviewApril 24, 2024 | americanbankingnews.comReviewing NeueHealth (NEUE) & The CompetitionApril 24, 2024 | americanbankingnews.comNeueHealth (NEUE) vs. Its Peers Head-To-Head ComparisonApril 24, 2024 | americanbankingnews.comComparing NeueHealth (NEUE) and Its CompetitorsSee More Headlines Receive NEUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/06/2024Today4/30/2024Next Earnings (Confirmed)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryN/A Current SymbolNYSE:NEUE Previous SymbolNYSE:NEUE CUSIPN/A CIK1671284 Webwww.brighthealthgroup.com Phone612-238-1321FaxN/AEmployees1,252Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+25.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($151.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,151,450,000.00 Net Margins-71.23% Pretax Margin-54.20% Return on EquityN/A Return on Assets-1.21% Debt Debt-to-Equity RatioN/A Current Ratio0.78 Quick Ratio0.78 Sales & Book Value Annual Sales$1.16 billion Price / Sales0.05 Cash Flow$63.83 per share Price / Cash Flow0.10 Book Value($158.35) per share Price / Book-0.04Miscellaneous Outstanding Shares8,220,000Free Float2,936,000Market Cap$52.46 million OptionableN/A Beta0.85 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Robert John Sheehy (Age 66)Co-Founder & Chairman Mr. George Lawrence Mikan III (Age 52)Vice Chairman, CEO & President Comp: $3.52MMr. Jay Stephen Matushak (Age 49)Chief Financial Officer Comp: $950.28kMr. Tomas Orozco (Age 48)Executive Vice President of Consumer Care Comp: $1.14MMr. Jeffrey Joseph SchermanChief Accounting OfficerMr. Jeff Craig (Age 41)General Counsel & Corporate Secretary Comp: $582.55kMs. Stacy ContiChief People OfficerMs. Megan NorthPresident of NeueSolutionsMr. Joaquin Baralt M.D.President of Value-Based CareMore ExecutivesKey CompetitorsBright Health GroupNYSE:BHGZepp HealthNYSE:ZEPPApyx MedicalNASDAQ:APYXGenenta ScienceNASDAQ:GNTAAVROBIONASDAQ:AVROView All CompetitorsInsidersGeorge Lawrence Mikan IIISold 4,990 sharesTotal: $36,277.30 ($7.27/share)Jay MatushakSold 1,083 sharesTotal: $7,873.41 ($7.27/share)Tomas OrozcoSold 822 sharesTotal: $5,975.94 ($7.27/share)Jeffrey J SchermanSold 568 sharesTotal: $4,129.36 ($7.27/share)Jeffery Michael CraigSold 260 sharesTotal: $1,890.20 ($7.27/share)View All Insider Transactions NEUE Stock Analysis - Frequently Asked Questions Should I buy or sell NeueHealth stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NeueHealth in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" NEUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEUE, but not buy additional shares or sell existing shares. View NEUE analyst ratings or view top-rated stocks. What is NeueHealth's stock price target for 2024? 1 Wall Street research analysts have issued 12 month price objectives for NeueHealth's shares. Their NEUE share price targets range from $8.00 to $8.00. On average, they anticipate the company's share price to reach $8.00 in the next year. This suggests a possible upside of 25.3% from the stock's current price. View analysts price targets for NEUE or view top-rated stocks among Wall Street analysts. How have NEUE shares performed in 2024? NeueHealth's stock was trading at $6.53 at the beginning of 2024. Since then, NEUE shares have decreased by 2.3% and is now trading at $6.3825. View the best growth stocks for 2024 here. When is NeueHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our NEUE earnings forecast. How can I listen to NeueHealth's earnings call? NeueHealth will be holding an earnings conference call on Wednesday, May 8th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were NeueHealth's earnings last quarter? NeueHealth, Inc. (NYSE:NEUE) released its quarterly earnings results on Wednesday, March, 6th. The company reported $20.07 earnings per share for the quarter. The company earned $292.87 million during the quarter. How do I buy shares of NeueHealth? Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:NEUE) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTracker#1 election stockPorter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBiden out June 13; Kamala won’t replace him?Paradigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
